GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,186,000 | +59.9% | 252,420 | +57.2% | 4.47% | +18.5% |
| Q1 2022 | $6,994,000 | +39.3% | 160,568 | +41.0% | 3.77% | +0.7% |
| Q4 2021 | $5,021,000 | +40.6% | 113,866 | +21.8% | 3.75% | +14.5% |
| Q3 2021 | $3,572,000 | +2.3% | 93,485 | +6.6% | 3.27% | +0.2% |
| Q2 2021 | $3,492,000 | +18.2% | 87,686 | +5.9% | 3.27% | +6.4% |
| Q1 2021 | $2,955,000 | -63.1% | 82,792 | -62.0% | 3.07% | -2.1% |
| Q4 2020 | $8,016,000 | +20.9% | 217,817 | +23.6% | 3.14% | -2.2% |
| Q3 2020 | $6,632,000 | +26.4% | 176,186 | +36.9% | 3.21% | +18.5% |
| Q2 2020 | $5,248,000 | +8.1% | 128,664 | +0.4% | 2.71% | -13.3% |
| Q1 2020 | $4,854,000 | -19.7% | 128,112 | -0.5% | 3.13% | +13.0% |
| Q4 2019 | $6,047,000 | +9.5% | 128,695 | -0.5% | 2.77% | +3.9% |
| Q3 2019 | $5,521,000 | +7.0% | 129,352 | +0.3% | 2.66% | +7.0% |
| Q2 2019 | $5,159,000 | – | 128,907 | – | 2.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |